View of EVALUATION OF THE PROFILE OF ADVERSE EVENT NOTIFICATIONS FOR IVERMECTIN AND NITAZOXANIDE BEFORE AND DURING THE COVID-19 PANDEMIC

Return to Issue Details EVALUATION OF THE PROFILE OF ADVERSE EVENT NOTIFICATIONS FOR IVERMECTIN AND NITAZOXANIDE BEFORE AND DURING THE COVID-19 PANDEMIC Download Download PDF